文献速递心脑血管急症重症综合管理与镇静镇痛

激活XBP1s/O-GlcNAcylation通路改善年轻与老年小鼠心脏骤停复苏后的功能结局

Activation of the XBP1s/O-GlcNAcylation Pathway Improves Functional Outcome After Cardiac Arrest and Resuscitation in Young and Aged Mice.
PubMed 文献 · Shock · 2021-01-01
一句话结论小鼠证据:神经元XBP1s通过上调O-GlcNAcylation发挥心脏骤停后神经保护,葡萄糖胺可改善年轻及老年小鼠复苏后行为学结局。

该研究利用功能缺失与功能获得小鼠遗传工具,首次证明心脏骤停复苏后脑内XBP1剪接分支(XBP1s)激活具有神经保护作用:神经元特异性Xbp1敲除小鼠结局更差,而神经元特异性表达Xbp1s的小鼠结局更好。因XBP1s在缺血条件下的保护作用由增加O-GlcNAcylation介导,研究者给予年轻小鼠葡萄糖胺,发现复苏后第3天功能缺损减轻。在确认葡萄糖胺可提升老年脑O-GlcNAcylation后,对8分钟心脏骤停的老年小鼠给予葡萄糖胺,行为学测试显著改善。提示XBP1s/O-GlcNAc通路是心脏骤停治疗有前景的靶点。

要点

  • 神经元特异性Xbp1敲除小鼠心脏骤停复苏后结局更差,提示内源性XBP1s通路在复苏后脑内具有保护作用。
  • 神经元特异性表达Xbp1s的小鼠心脏骤停复苏后结局更好,为功能获得性证据。
  • 年轻小鼠心脏骤停后给予葡萄糖胺,复苏后第3天功能缺损减轻。
  • 老年小鼠经历8分钟心脏骤停后给予葡萄糖胺,行为学测试显著优于对照。
  • 上述为小鼠遗传学与药物干预临床前证据,尚不能直接转化为急诊/ICU人体推荐。

适用人群与场景

  • 研究人群为小鼠:年轻小鼠与老年小鼠,均经历心脏骤停与复苏;老年小鼠具体为8分钟心脏骤停模型。
  • 原文未提及人体适用人群、纳入或排除标准。

诊断标准与关键阈值

  • 原文未提及临床诊断标准、评分界值或启动/停止阈值。

处置流程与药物剂量

  • 年轻小鼠心脏骤停后给予葡萄糖胺处理,复苏后第3天评估功能缺损减轻;原文未提及葡萄糖胺的具体剂量、单位、给药途径、频次或疗程。
  • 老年小鼠在8分钟心脏骤停后给予葡萄糖胺处理,行为学测试显著改善;原文未提及具体剂量、单位、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及临床红旗征或需立刻处理的情况。

研究设计与关键结果

  • 研究类型为小鼠遗传学功能缺失与功能获得实验及药物干预实验;样本量、中心数原文未提及。
  • 神经元特异性Xbp1敲除小鼠心脏骤停结局更差;神经元特异性表达Xbp1s的小鼠结局更好。
  • 年轻小鼠心脏骤停后葡萄糖胺处理组复苏后第3天功能缺损减轻。
  • 老年小鼠8分钟心脏骤停后葡萄糖胺处理组行为学测试显著改善。

证据类型、等级与局限

  • 证据类型为动物实验(小鼠遗传学工具与药物干预),非RCT、队列或人体研究。
  • 局限:仅限小鼠临床前研究,尚未在人体验证;原文未提及样本量、盲法或随机化细节。

对床旁实践的改变

  • 该内容为临床前机制研究,暂不能改变急诊/ICU对心脏骤停复苏后患者的具体处置;不适用于据此在人体使用葡萄糖胺。
  • 原文未提及适用与不适用人群及常见陷阱。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

After cardiac arrest (CA) and resuscitation, the unfolded protein response (UPR) is activated in various organs including the brain. However, the role of the UPR in CA outcome remains largely unknown. One UPR branch involves spliced X-box-binding protein-1 (XBP1s). Notably, XBP1s, a transcriptional factor, can upregulate expression of specific enzymes related to glucose metabolism, and subsequently boost O-linked β-N-acetylglucosamine modification (O-GlcNAcylation). The current study is focused on effects of the XBP1 UPR branch and its downstream O-GlcNAcylation on CA outcome. Using both loss-of-function and gain-of-function mouse genetic tools, we provide the first evidence that activation of the XBP1 UPR branch in the post-CA brain is neuroprotective. Specifically, neuron-specific Xbp1 knockout mice had worse CA outcome, while mice with neuron-specific expression of Xbp1s in the brain had better CA outcome. Since it has been shown that the protective role of the XBP1s signaling pathway under ischemic conditions is mediated by increasing O-GlcNAcylation, we then treated young mice with glucosamine, and found that functional deficits were mitigated on day 3 post CA. Finally, after confirming that glucosamine can boost O-GlcNAcylation in the aged brain, we subjected aged mice to 8 min CA, and then treated them with glucosamine. We found that glucosamine-treated aged mice performed significantly better in behavioral tests. Together, our data indicate that the XBP1s/O-GlcNAc pathway is a promising target for CA therapy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Li R, Shen Y, Li X, et al. Activation of the XBP1s/O-GlcNAcylation Pathway Improves Functional Outcome After Cardiac Arrest and Resuscitation in Young and Aged Mice. Shock. 2021. PMID: 34652341. doi:10.1097/SHK.0000000000001732

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。